Double dose vaccine induces lower antibodies to Omicron, studies

December 14, 2021:

British scientists have found that a double dose of COVID-19 vaccine therapy does not induce sufficient neutralizing antibodies against the omicron coronavirus variant. This indicates that infections in previously infected or vaccinated individuals may increase.

Researchers at the University of Oxford have analyzed blood samples from participants receiving doses from AstraZeneca-Oxford or Pfizer-BioNTech in a large study investigating vaccine mixes, a study that has not yet been peer-reviewed. Results were announced on Monday.

The results warned that British Prime Minister Boris Johnson wasn’t enough to contain Omicron after last week’s findings from the British Health Agency that boosters would significantly restore protection against mutants. It will be held the next day.

A study from the University of Oxford shows that low levels of antibodies that fight infection against Omicron can increase the risk of serious illness, hospitalization, or death in people who receive two doses of the approved vaccine. Not yet.

“These data are important, but only part of the big picture. We will only look at neutralizing antibodies after the second dose, but they will not tell us about cell-mediated immunity. This will also be tested.” Said Matthew Snape, Professor and Collaborator of Oxford. -The author of the paper. ET HealthWorld